Abstract
Natural killer (NK) cells are lymphocytes that function as part of the innate immune system. Their activity is controlled by a range of inhibitory and activating receptors, including the important killer-cell immunoglobulin-like receptors (KIR). The KIR are a multi-gene family of receptors that interact with the human leukocyte antigen (HLA) class I family of molecules and are characterised by extensive allelic polymorphism. Their expression on the cell surface of NK cells is highly variable, but the factors responsible for this variability are not yet clearly understood. In the current study, we investigated KIR expression in a healthy human cohort that we had previously characterised in depth at a genetic level, with KIR allele typing and HLA class I ligand genotypes available for all donors (n=198). Allelic polymorphism significantly affected the phenotypic expression of all KIR analysed, whereas HLA ligand background influenced the expression levels of 2DL1 and 2DL3. In particular, we found that although 2DL2 may influence 2DL1 expression, this appears to be owing to variation in 2DL1 copy number. Finally, the inhibitory receptor LILRB1 had higher expression levels in individuals with B/B KIR genotypes, suggesting a possible relationship between KIR and non-KIR receptors, which serves to balance NK cell activation potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
O'Connor GM, Hart OM, Gardiner CM . Putting the natural killer cell in its place. Immunology 2006; 117: 1–10.
Cerwenka A, Lanier LL . Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41–49.
Vilches C, Parham P . KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217–251.
Robinson J, Waller MJ, Stoehr P, Marsh SG . IPD—the immuno polymorphism database. Nucleic Acids Res 2005; 33 Database issue D523–D526.
Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166: 2992–3001.
Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P et al. Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur J Immunol 2013; 43: 1085–1098.
Thomas R, Yamada E, Alter G, Martin MP, Bashirova AA, Norman PJ et al. Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 2008; 180: 6743–6750.
Goodridge JP, Lathbury LJ, Steiner NK, Shulse CN, Pullikotil P, Seidah NG et al. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol 2007; 37: 199–211.
Goodridge JP, Witt CS, Christiansen FT, Warren HS . KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003; 171: 1768–1774.
Middleton D, Gonzalez A, Gilmore PM . Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol 2007; 68: 128–134.
Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P . Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203: 633–645.
Schonberg K, Sribar M, Enczmann J, Fischer JC, Uhrberg M . Analyses of HLA-C-specific KIR repertoires in donors with group. A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2011; 117: 98–107.
Beziat V, Traherne JA, Liu LL, Jayaraman J, Enqvist M, Larsson S et al. Influence of KIR gene copy number on natural killer cell education. Blood 2013; 121: 4703–4707.
Wright PW, Li H, Huehn A, O'Connor GM, Cooley S, Miller JS et al. Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression. Genes Immun 2014; 15: 440–448.
Li H, Pascal V, Martin MP, Carrington M, Anderson SK . Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008; 4: e1000254.
Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M . Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur J Immunol 2013; 43: 480–487.
Guinan KJ, Cunningham RT, Meenagh A, Gonzalez A, Dring MM, McGuinness BW et al. Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes. Genes Immun 2010; 11: 467–478.
Babor F, Manser AR, Fischer JC, Scherenschlich N, Enczmann J, Chazara O et al. KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse. Blood 2014; 124: 2248–2251.
Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM . Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 2010; 11: 67–78.
Uhrberg M, Parham P, Wernet P, Definition of gene content for nine common group. B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221–229.
Beziat V, Traherne J, Malmberg JA, Ivarsson MA, Bjorkstrom NK, Retiere C et al. Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur J Immunol 2014; 44: 2192–2196.
Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P . The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171: 6640–6649.
Lanier LL . NK cell recognition. Annu Rev Immunol 2005; 23: 225–274.
Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE . The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res 2006; 35: 263–278.
Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH . Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol 2011; 89: 216–224.
Middleton D, Curran M, Maxwell L . Natural killer cells and their receptors. Transpl Immunol 2002; 10: 147–164.
Brown D, Trowsdale J, Allen R . The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004; 64: 215–225.
Bari R, Bell T, Leung WH, Vong QP, Chan WK, Das Gupta N et al. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 2009; 114: 5182–5190.
Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ . KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009; 114: 95–104.
Beziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013; 121: 2678–2688.
Davidson CL, Li NL, Burshtyn DN . LILRB1 polymorphism and surface phenotypes of natural killer cells. Hum Immunol 2010; 71: 942–949.
Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012; 22: 1845–1854.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Genes and Immunity website
Supplementary information
Rights and permissions
About this article
Cite this article
Dunphy, S., Guinan, K., Chorcora, C. et al. 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells. Genes Immun 16, 301–310 (2015). https://doi.org/10.1038/gene.2015.15
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2015.15
This article is cited by
-
The KIR2DL1 intermediate upstream element participates in gene activation
Immunogenetics (2023)
-
Improved full-length killer cell immunoglobulin-like receptor transcript discovery in Mauritian cynomolgus macaques
Immunogenetics (2017)
-
qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination
Genome Medicine (2016)
-
Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes
Genes & Immunity (2016)
-
The characteristics of NK cells in Schistosoma japonicum-infected mouse spleens
Parasitology Research (2015)